Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
US feed additives firm BV Science has increased its presence in Europe after opening a new distribution center in Budapest, Hungary.
Covetrus has posted sales of around $1 billion for the second quarter of 2019, representing a flat year-on-year comparison.
Boehringer Ingelheim has opened a new animal health management center in Shanghai, China.
Elanco's second-quarter revenues have been impacted by foreign currency exchange rates and the firm has scaled back its full-year forecast due to African swine fever (ASF).
ImmuCell has seen its sales drop in Q2 2019, after previously recording its "best quarter ever".
Texas-based Volition has established Volition Veterinary Diagnostics (VVG) – a veterinary subsidiary to its human life sciences division.
US companion animal medication provider PetIQ has again recorded 29% quarterly sales growth.
Kindred Biosciences chief executive Richard Chin has said the firm is aiming to launch its monoclonal antibody candidate against canine parvovirus by the end of 2020 or early 2021.
Zoetis expects to gain approval for a new monoclonal antibody (mAb) to control pain associated with osteoarthritis in cats in 2021.
Polish start-up Bioceltix is seeking EU Good Manufacturing Practice certification to produce its mesenchymal stromal cell product candidates by the end of 2019.
Swedish business Intervacc has finalized production of its vaccine for equine strangles on a commercial scale.
St Louis, Missouri-headquartered Vetio Animal Health has completed the expansion of its Montreal plant expansion.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.